Date: 2015-05-11
Type of information: Distribution agreement
Compound: biotherapy monitoring range LISA TRACKER
Company: Theradiag (France) Somagen Diagnostics (Canada)
Therapeutic area:
Type agreement: distribution
Action mechanism: theranostic test
Disease:
Details:
- • On May 11, 2015, Theradiag, a company specializing in theranostics and in vitro diagnostics, announced that it has entered into an exclusive distribution agreement with the Canadian company Somagen Diagnostics., for the launch in Canada of its biotherapy monitoring range LISA TRACKER.
Somagen Diagnostics Inc. is one of the key providers of diagnostics products in Canada, specialized in the distribution of innovative products in niche markets. Somagen Diagnostics Inc. will manage the promotion, marketing and installation of LISA TRACKER kits in the country through a dedicated salesforce. It will also convey recent scientific developments regarding biotherapy monitoring with Canadian KOLs.
Canada is the second largest market in North America in terms of anti-TNF sales. It has one of the highest prevalence of Crohn’s Disease and Ulcerative Colitis in the world. LISA TRACKER kits are currently registered for sale in the European Union, North Africa, the Middle-East, India and Australia. They were registered in Canada in 2014.
Financial terms:
Latest news:
Is general: Yes
